Interleukin-6 produced in subcutaneous adipose tissue is linked to blood pressure control in septic patients

Cytokine

Volumn 50, Issue 3, 2010, Pages 284-291

  Ikeoka, Dimas ^a   Pachler, Christoph ^a   Korsatko, Stefan ^a   Mader, Julia K ^a   Weinhandl, Heinz ^a   Bodenlenz, Manfred ^b   Plank, Johannes ^a   Smolle, Karl Heinz ^a   Ellmerer, Martin ^a   Pieber, Thomas R ^a,b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b JOANNEUM RESEARCH   (Austria)

Author keywords

Adipose tissue; Blood pressure; Cytokines; Inflammation; Sepsis

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; BODY TEMPERATURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIASTOLIC BLOOD PRESSURE; FEMALE; GENE EXPRESSION PROFILING; GLOMERULUS FILTRATION RATE; HEART RATE; HUMAN; LEUKOCYTE COUNT; MALE; PERFUSION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEPSIS; SUBCUTANEOUS FAT; SYSTOLIC BLOOD PRESSURE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTHROPOMETRY; BLOOD PRESSURE; DIASTOLE; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SEPSIS; SUBCUTANEOUS FAT; TIME FACTORS; YOUNG ADULT;

EID: 77952493517     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.02.015     Document Type: Article

References (32)

1. Bone R.C. Sepsis, the sepsis syndrome, multi-organ failure: a plea for comparable definitions. Ann Intern Med 1991, 114:332-333.
2. Bone R.C. Sepsis, sepsis syndrome, and the systemic inflammatory response syndrome (SIRS). Gulliver in Laputa. JAMA 1995, 273:155-156.
3. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Intensive Care Med 2003, 29:530-538.
4. Casey L.C., Balk R.A., Bone R.C. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993, 119:771-778.
5. Hotchkiss R.S., Karl I.E. The pathophysiology and treatment of sepsis. N Engl J Med 2003, 348:138-150.
6. Mathison J.C., Wolfson E., Ulevitch R.J. Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. J Clin Invest 1988, 81:1925-1937.
7. Michie H.R., Spriggs D.R., Manogue K.R., Sherman M.L., Revhaug A., O'Dwyer S.T., et al. Tumor necrosis factor and endotoxin induce similar metabolic responses in human beings. Surgery 1988, 104:280-286.
8. Suffredini A.F., Fromm R.E., Parker M.M., Brenner M., Kovacs J.A., Wesley R.A., et al. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 1989, 321:280-287.
9. Beasley D., Eldridge M. Interleukin-1 beta and tumor necrosis factor-alpha synergistically induce NO synthase in rat vascular smooth muscle cells. Am J Physiol 1994, 266:R1197-R1203.
10. Cunha F.Q., Assreuy J., Moss D.W., Rees D., Leal L.M., Moncada S., et al. Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: role of TNF-alpha and IL-1-beta. Immunology 1994, 81:211-215.
11. Antonelli M., Raponi G.M., Martino P., Rosa G., Conti G., Jalouk J., et al. High IL-6 serum levels are associated with septic shock and mortality in septic patients with severe leukopenia due to hematological malignancies. Scand J Infect Dis 1995, 27:381-384.
12. Avontuur J.A., Stam T.C., Jongen-Lavrencic M., van Amsterdam J.G., Eggermont A.M., Bruining H.A., et al. Effect of L-NAME, an inhibitor of nitric oxide synthesis, on plasma levels of IL-6, IL-8, TNF alpha and nitrite/nitrate in human septic shock. Intensive Care Med 1998, 24:673-679.
13. Hotamisligil G.S., Peraldi P., Budavari A., Ellis R., White M.F., Spiegelman B.M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 1996, 271:665-668.
14. Stith R.D., Luo J. Endocrine and carbohydrate responses to interleukin-6 in vivo. Circ Shock 1994, 44:210-215.
15. Bastard J.P., Maachi M., Lagathu C., Kim M.J., Caron M., Vidal H., et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006, 17:4-12.
16. Klein S., Coppack S.W., Mohamed-Ali V., Landt M. Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes 1996, 45:984-987.
17. Mohamed-Ali V., Goodrick S., Bulmer K., Holly J.M., Yudkin J.S., Coppack S.W. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo. Am J Physiol 1999, 277:E971-E975.
18. Mohamed-Ali V., Goodrick S., Rawesh A., Katz D.R., Miles J.M., Yudkin J.S., et al. Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo. J Clin Endocrinol Metab 1997, 82:4196-4200.
19. Pachler C., Ikeoka D., Plank J., Weinhandl H., Suppan M., Mader J.K., et al. Subcutaneous adipose tissue exerts proinflammatory cytokines after minimal trauma in humans. Am J Physiol Endocrinol Metab 2007, 293:E690-E696.
20. Ellmerer M., Schaupp L., Brunner G.A., Sendlhofer G., Wutte A., Wach P., et al. Measurement of interstitial albumin in human skeletal muscle and adipose tissue by open-flow microperfusion. Am J Physiol Endocrinol Metab 2000, 278:E352-E356.
21. Schaupp L., Ellmerer M., Brunner G.A., Wutte A., Sendlhofer G., Trajanoski Z., et al. Direct access to interstitial fluid in adipose tissue in humans by use of open-flow microperfusion. Am J Physiol 1999, 276:E401-E408.
22. Knaus W.A., Draper E.A., Wagner D.P., Zimmerman J.E. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829.
23. Vignali D.A. Multiplexed particle-based flow cytometric assays. J Immunol Methods 2000, 243:243-255.
24. Orban Z., Remaley A.T., Sampson M., Trajanoski Z., Chrousos G.P. The differential effect of food intake and beta-adrenergic stimulation on adipose-derived hormones and cytokines in man. J Clin Endocrinol Metab 1999, 84:2126-2133.
25. Sopasakis V.R., Sandqvist M., Gustafson B., Hammarstedt A., Schmelz M., Yang X., et al. High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator. Obes Res 2004, 12:454-460.
26. Murdolo G., Herder C., Wang Z., Rose B., Schmelz M., Jansson P.A. In situ profiling of adipokines in subcutaneous microdialysates from lean and obese individuals. Am J Physiol Endocrinol Metab 2008, 295:E1095-E1105.
27. Ferreira S.H., Lorenzetti B.B., Cunha F.Q., Poole S. Bradykinin release of TNF-alpha plays a key role in the development of inflammatory hyperalgesia. Agents Actions 1993, 38:C7-C9.
28. Pan Z.K., Ye R.D., Christiansen S.C., Jagels M.A., Bokoch G.M., Zuraw B.L. Role of the Rho GTPase in bradykinin-stimulated nuclear factor-kappaB activation and IL-1beta gene expression in cultured human epithelial cells. J Immunol 1998, 160:3038-3045.
29. Saleh T.S., Calixto J.B., Medeiros Y.S. Pro-inflammatory effects induced by bradykinin in a murine model of pleurisy. Eur J Pharmacol 1997, 331:43-52.
30. Zhu Y.M., Bradbury D.A., Pang L., Knox A.J. Transcriptional regulation of interleukin (IL)-8 by bradykinin in human airway smooth muscle cells involves prostanoid-dependent activation of AP-1 and nuclear factor (NF)-IL-6 and prostanoid-independent activation of NF-kappaB. J Biol Chem 2003, 278:29366-29375.
31. Ross G., Hubschle T., Pehl U., Braun H.A., Voigt K., Gerstberger R., et al. Fever induction by localized subcutaneous inflammation in guinea pigs: the role of cytokines and prostaglandins. J Appl Physiol 2003, 94:1395-1402.
32. Bozza F.A., Salluh J.I., Japiassu A.M., Soares M., Assis E.F., Gomes R.N., et al. Cytokine profiles as markers of disease severity in sepsis: a multiplex analysis. Crit Care 2007, 11:R49.